Amir Nashat
QuietNamed in filings at Polaris Partners
- Board seats filed
- 16
all filings on record
Named in filings at Polaris Partners
all filings on record
last 24 months
from a verified or cited source
| Primmune Therapeutics | Biotech & pharma | October 2020 | None on file |
| Dewpoint Therapeutics | Biotech & pharma | July 2020 | None on file |
| Freenome Holdings | Biotech & pharma | June 2019 | None on file |
| Morphic Holding | Biotech & pharma | September 2018 | None on file |
| Camp4 Therapeutics | Biotech & pharma | April 2018 | None on file |
| Syros Pharmaceuticals | Biotech & pharma | January 2018 | ARCH Venture Partners, Samsara Biocapital |
| Scholar Rock Holding | Biotech & pharma | December 2017 | ARCH Venture Partners |
| Sofregen Medical | Medical devices | September 2016 | None on file |
| 1366 TECHNOLOGIES | Climate & energy | April 2016 | North Bridge Venture Partners |
| Scholar Rock | Biotech & pharma | December 2015 | ARCH Venture Partners |
| FATE THERAPEUTICS | Biotech & pharma | May 2015 | None on file |
| aTYR PHARMA | Biotech & pharma | March 2015 | Chemistry Ventures, Domain Partners |
| Metacrine | Biotech & pharma | January 2015 | ARCH Venture Partners, Venbio Global Strategic, Venbio Select |
| SELECTA BIOSCIENCES | Biotech & pharma | April 2014 | Caduceus Capital, Kendall Capital Partners, Orbimed Asia Partners, Orbimed Genesis |
| Receptos | Biotech & pharma | February 2012 | ARCH Venture Partners |
| PROMEDIOR | Biotech & pharma | February 2012 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Amir Nashat on the board, based on 16 filed seats with a verified or cited source.